17th week of 2010 patent applcation highlights part 50 |
Patent application number | Title | Published |
20100105901 | SYNTHESIS METHOD OF POLYMER COMPLEX CRYSTAL - Disclosed is a synthesis method for synthesizing in a short time and selectively a microcrystal of a polymer complex having three three-dimensionally and regularly arranged channels. | 2010-04-29 |
20100105902 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex - An organometallic complex is provided by which favorable red-color light emission can be obtained. Further, an organometallic complex having a peak of light emission at about 620 nm is provided because the wavelength of light which is perceived as excellent red-color light is about 620 nm. Furthermore, an organometallic complex is provided by which red-color light emission with high luminous efficiency (cd/A) can be obtained. An organometallic complex represented by the following general formula (G2) and a light-emitting element, a light-emitting device, and an electronic device including the organometallic complex represented by the following general formula (G2) are provided. | 2010-04-29 |
20100105904 | UREA TYPE CINNAMIDE DERIVATIVE - Disclosed is a compound represented by the formula (I) below or a pharmacologically acceptable salt thereof. Also disclosed is a use of the compound or salt as a pharmaceutical product. | 2010-04-29 |
20100105905 | EP2 Agonists - The invention provides EP2 agonists, methods for their preparation, pharmaceutical compositions containing these compounds, and methods of using these compounds and compositions for lowering intraocular pressure and thereby treating glaucoma. | 2010-04-29 |
20100105906 | NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES - This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula | 2010-04-29 |
20100105907 | CONTINUOUS ANTISOLVENT CRYSTALLIZATION PROCESS AND SYSTEM USING PLUG FLOW REACTORS - A process and system for continuous crystallization of a compound using antisolvent addition in which a solution is prepared with an organic compound and a solvent. An antisolvent is added to the solution in a continuous plug flow system comprising at least one process module. The antisolvent can be added in multiple addition points such that the overall amount of antisolvent added to the continuous plug flow reactor remains fixed. The multiple addition point technique provides every process module with an equal volume of antisolvent. Finally, crystals are recovered from the slurry upon exiting the system. Preferably, the mean crystal size is less than 100 μm. | 2010-04-29 |
20100105908 | Process For The Preparation Of Levocetirizine And Intermediates Thereof - The present invention describes a novel process for the preparation of levocetirizine and pharmaceutically acceptable acid addition salts thereof using diglycolic acid or derivatives thereof and new intermediates used in that process. | 2010-04-29 |
20100105909 | MODIFIED METAL COMPLEX AND USE THEREOF - A modified metal complex obtained by subjecting a metal complex containing an organic compound having one nitrogen-containing aromatic heterocycle and four or more structures of a phenol, thiophenol, aniline or nitrogen-containing aromatic heterocyclic ring or an organic compound having two or more phenol rings and three or more nitrogen-containing aromatic heterocycles, in its molecule as a ligand, to a heating, radiation irradiation or discharge treatment until a mass reduction rate after the treatment becomes from 1 to 90 mass %, thereby the complex shows a carbon content after the treatment of 5 mass % or more. | 2010-04-29 |
20100105910 | BLOCKING AGENTS FOR ORGANOBORANE COMPOUNDS - An organoborane complex is disclosed. The complex includes a blocking agent comprising a bifunctional Lewis base. The blocking agents include an amine group and a second functional group that has a lower Lewis basicity than the first functional group. The blocking is based on amino alkyl pyridines. | 2010-04-29 |
20100105911 | (S)-N-methylnal trexone - This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use. | 2010-04-29 |
20100105912 | FLUORO-CONTAINING DERIVATIVES OF HYDROGENATED PYRIDO[4,3-b]INDOLES WITH NEUROPROTECTIVE AND COGNITION ENHANCING PROPERTIES, PROCESS FOR PREPARING, AND USE - Some exemplary embodiments comprise fluoro-containing derivatives of pyrido[4,3-b]indoles (and exemplary methods of making the same) that may be administered to a mammal (including a human) in an effective amount for potential use in the treatment or prophylaxis of neurological disorders including AD, mild cognitive impairment, senile and vascular dementia, HD, ALS, Parkinson's disease, AIDS-related dementia, ischaemic cerebral pathologies, neuropathic pain, ADHD (attention deficit disorder/hyperactivity syndrome), eating disorders such as anorexia and bulimia, panic attacks, withdrawal from drug abuse such as cocaine, ethanol, nicotine and benzodiazepines, schizophrenia (in particular the cognitive deficit of schizophrenia), stroke and also disorders associated with spinal trauma and/or head injury. These derivatives may also be useful for the treatment of borderline personality disorder, obesity, and for use as geroprotectors. The compounds may also be used as “pharmacological tools” for an investigation of the mechanism of protection against neurodegeneration disorders in vivo or in vitro. | 2010-04-29 |
20100105914 | CASPASE INHIBITORS AND USES THEREOF - The present invention provides a compound of formula I: | 2010-04-29 |
20100105915 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS - Heterocyclic compounds that bind chemokine receptors and inhibit the binding of their natural ligands are disclosed. The invention compounds are protective against infection by HIV and exert effects characteristic of antagonists to the CXCR4 receptor. | 2010-04-29 |
20100105916 | Processes for Preparing Donepezil - A process for preparing highly pure donepezil, particularly donepezil hydrochloride, is provided comprising hydrogenating compound 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-ylidene]methyl-piperidine or its hydrochloride salt with a noble metal catalyst or a derivative thereof, in the presence of at least one additive, wherein the additive contains at least one heteroatom, e.g., a sulfur, phosphorous, or nitrogen heteroatom. | 2010-04-29 |
20100105917 | METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF - The present invention relates to a method for producing an optically active 3-aminopiperidine or salt thereof. In the method, a racemic nipecotamide is stereoselectively hydrolyzed to obtain an optically active nipecotamide and an optically active nipecotic acid in the presence of an enzyme source derived from an organism, and then the optically active nipecotamide is derived into an optically active aminopiperidine or salt thereof by aroylation, Hofmann rearrangement, deprotection of the amino group and further deprotection; or the optically active nipecotamide is derived into an optically active aminopiperidine or salt thereof by selective protection with BOC, Hofmann rearrangement and further deprotection. It is possible by the present invention to produce an optically active 3-aminopiperidine or salt thereof useful as a pharmaceutical intermediate from an inexpensive and easily available starting material by easy method applicable to industrial manufacturing. | 2010-04-29 |
20100105918 | METAL COMPLEX, LIGHT-EMITTING DEVICE AND DISPLAY - A novel luminescent metal complex comprises a composition of [(Pt | 2010-04-29 |
20100105919 | METHOD FOR THE PREPARATION OF ZOLMITRIPTAN - In the preparation of zolmitriptan of formula III the reduction of the diazonium salt to (5)-4-(4-hydrazinobenzyl)-1,3-oxazolidin-2-one of formula IV is performed in a more concentrated mixture and by the effect on an alkali metal disulphite, preferably sodium disulphite. A zolmitriptan toluene solvate, characterized by a toluene content of 9 to 14% by weight according to the gas chromatography determination and by a maximum of the corresponding mass loss at temperatures of about 111° C. in the gravimetric analysis record. A zolmitriptan toluene solvate, showing strong Raman bands at the wave numbers of 1443 and 1354 cm | 2010-04-29 |
20100105920 | PREPARATION OF ISOXAZOLIN-3-YLACYLBENZENES - A process is described for preparing isoxazoles of the formula I | 2010-04-29 |
20100105921 | N-HETEROCYCLIC CARBENE (NHC) CATALYZED SYNTHESIS OF HYDROXAMIC ACIDS - A process for preparing hydroxamic acids is provided. The process comprises reacting an aldehyde with a nitroso compound in the presence of a N-heterocyclic carbene (NHC) catalyst. | 2010-04-29 |
20100105922 | PROCESS FOR PRODUCING FUSED IMIDAZOLE COMPOUND, REFORMATSKY REAGENT IN STABLE FORM, AND PROCESS FOR PRODUCING THE SAME - The present invention provides an industrially advantageous process for producing a steroid C | 2010-04-29 |
20100105923 | PROCESS FOR PRODUCTION OF HYDROXYADAMANTANEAMINE - Disclosed is a process for producing 1-hydroxy-4-aminoadamantane. | 2010-04-29 |
20100105924 | PROCESSES OF PRODUCING GLUTAMIC ACID COMPOUNDS AND PRODUCTION INTERMEDIATES THEREFORE AND NOVEL INTERMEDIATE FOR THE PROCESSES - The present invention relates to processes of producing glutamic acid compounds, for example, monatin, which are useful as, for example, production intermediates for sweetener or pharmaceutical products. | 2010-04-29 |
20100105925 | NOVEL PROCESS FOR PREPARATION OF DULOXETINE HYDROCHLORIDE - An improved process for synthesis of duloxetine hydrochloride (1) having chiral purity greater than 99.9% that is characterized by the following:
| 2010-04-29 |
20100105926 | POLYNARY METAL OXIDE PHOSPHATE - A novel polynary metal oxide phosphate of the general formula I | 2010-04-29 |
20100105927 | POLYNARY VANADYL PYROPHOSPHATE - A novel polynary vanadyl pyrophosphate of the general formula I | 2010-04-29 |
20100105928 | METHODS FOR MASSIVE CULTURE OF DINOPHYSIS ACUMINATA AND ISOLATION OF PECTENOTOXIN-2 - Provided is a method for massive culture of | 2010-04-29 |
20100105929 | PROCESS FOR THE PREPARATION OF y-BUTYROLACTONES - The present invention relates to a process for the preparation of γ-butyrolactones. | 2010-04-29 |
20100105930 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES - The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols. | 2010-04-29 |
20100105931 | BIS(TETRAHYDROFURAN) COMPOUND, METHOD FOR PRODUCTION OF THE COMPOUND, AND USE OF THE COMPOUND - The present invention provides a new bis(tetrahydrofuran) compound having an excellent neurotrophic factor activity-enhancing effect, and a process for producing the same. The bis(tetrahydrofuran) compound of the present invention is represented by formula (1): | 2010-04-29 |
20100105932 | RECOVERY OF COMPONENTS MAKING UP A LIQUID MIXTURE - A process for recovering hexafluoropropylene and hexafluoropropylene oxide from a liquid mixture of these components is provided. The process includes, in a stripping stage, contacting the mixture with a gaseous stripping agent, thereby to strip hexafluoropropylene from the mixture. A gaseous product comprising hexafluoropropylene and gaseous stripping agent is withdrawn from the stripping stage, as is a liquid product comprising hexafluoropropylene oxide. | 2010-04-29 |
20100105933 | LIPID NANOPARTICLE BASED COMPOSITIONS AND METHODS FOR THE DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES - The present invention relates to novel cationic lipids, transfection agents, microparticles, nanoparticles, and short interfering nucleic acid (siNA) molecules. The invention also features compositions, and methods of use for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity in a subject or organism. Specifically, the invention relates to novel cationic lipids, microparticles, nanoparticles and transfection agents that effectively transfect or deliver biologically active molecules, such as antibodies (e.g., monoclonal, chimeric, humanized etc.), cholesterol, hormones, antivirals, peptides, proteins, chemotherapeutics, small molecules, vitamins, co-factors, nucleosides, nucleotides, oligonucleotides, enzymatic nucleic acids, antisense nucleic acids, triplex forming oligonucleotides, 2,5-A chimeras, dsRNA, allozymes, aptamers, decoys and analogs thereof, and small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), short hairpin RNA (shRNA), and RNAi inhibitor molecules, to relevant cells and/or tissues, such as in a subject or organism. Such novel cationic lipids, microparticles, nanoparticles and transfection agents are useful, for example, in providing compositions to prevent, inhibit, or treat diseases, conditions, or traits in a cell, subject or organism. The compositions described herein are generally referred to as formulated molecular compositions (FMC) or lipid nanoparticles (LNP). | 2010-04-29 |
20100105934 | FULVESTRANT INTERMEDIATE - A compound of formula (1) | 2010-04-29 |
20100105935 | PROCESS FOR CONTINUOUSLY PREPARING FATTY ACID METHYL ESTERS OR FATTY ESTERS - In a process for producing fatty acid methyl ester (FAME) from fats or oils by transesterification with methanol in the presence of an alkaline catalyst in at least two reaction stages traversed in succession, each consisting of a stirred-tank reactor and a downstream separator, a phase containing FAME and a phase containing glycerol are generated, which are separated in the separator, wherein the phase containing FAME is recirculated into the stirred-tank reactor of the next succeeding reaction stage and the phase containing glycerol is recirculated into the stirred-tank reactor of the first reaction stage, and the crude FAME withdrawn from the separator of the last reaction stage is transferred into a separator and the FAME withdrawn is dried. To increase the yield of FAME, the aqueous phase containing glycerol, methanol, undissociated soaps and FAME, which is obtained upon withdrawal of the FAME, is thoroughly mixed with the phases withdrawn from the separators of the first to penultimate reaction stages, which contain glycerol and FAME, and the mixture is separated in a separator into a phase containing FAME and a phase containing glycerol. | 2010-04-29 |
20100105936 | METAL-CONTAINING COMPOUND, ITS PRODUCTION METHOD, METAL-CONTAINING THIN FILM, AND ITS FORMATION METHOD - A compound which has thermal stability and moderate vaporizability and is satisfactory as a material for the CVD or ALD method; a process for producing the compound; a thin film formed from the compound as a raw material; and a method of forming the thin film. A compound represented by the general formula (1) is produced by reacting a compound represented by the general formula (2) with a compound represented by the general formula (3). The compound produced is used as a raw material to form a metal-containing thin film. [Chemical formula 1] (1) [Chemical formula 2] (2) [Chemical formula 3] M | 2010-04-29 |
20100105937 | COMPOUND HAVING ASYMMETRIC CARBON ATOM, OXIDATION-REDUCTION REACTION CAUSING PORTION, AND LIQUID CRYSTAL SUBSTITUENT - Disclosed is a compound represented by Formula (1). In Formula (1), * represents an asymmetric carbon atom; L and L′ each independently represent a divalent linking group; Rd represents an oxidation-reduction reaction causing portion; B and B′ each independently represent a liquid crystal substituent; D represents an arylene group, a hetero arylene group, or a divalent alicyclic hydrocarbon group; R represents a substituent; x represents 0 or 1; z represents an integer of from 0 to 3; w represents 0 or 1; n represents 0 or 1; v represents an integer of from 0 to 5; when z is 2 or more, plural B′s may be the same or different; and when v is 2 or more, plural R′s may be the same or different. | 2010-04-29 |
20100105938 | SILYL (METH)ACRYLATE COMPOUND CONTAINING A SILOXY GROUP HAVING A BULKY SUBSTITUENT AND ITS PRODUCTION METHOD - A silyl (meth)acrylate compound containing a siloxy group having a bulky substituent is provided. The compound is represented by the following general formula (1): | 2010-04-29 |
20100105939 | PHOSPHORUS-CONTAINING COMPOUND AND METHOD FOR PREPARING THE SAME - The present invention provides a phosphorus-containing compound of formula (I): | 2010-04-29 |
20100105940 | FULL CATALYST, PRODUCTION THEREOF, AND USE THEREOF IN AN AMMOXIDATION PROCESS - Catalysts comprising: (a) a support material comprising a component selected from the group consisting of aluminum oxide, silicon dioxide, aluminum silicate, magnesium silicate, titanium dioxide, zirconium dioxide, thorium dioxide, silicon carbide, and mixtures thereof; and (b) an active material comprising a mixture of vanadium (V) and antimony (Sb) and tungsten (W) and/or molybdenum (Mo), and optionally, at least one alkali metal, wherein the vanadium, antimony, tungsten and/or molybdenum and at least one alkali metal are each present in oxidic form; wherein the support material is provided in a form selected from the group of shapes consisting of spherical or approximately spherical and having a diameter of 2 to 10 mm, tubular or rod-shaped and having a diameter of 1 to 10 mm and a length of 2 to 20 mm, granular having a maximum diameter of 2 to 20 mm, and combinations thereof; and wherein the catalyst is diluted with an inert material; along with processes for preparing such catalysts and their use in preparing nitriles via gas phase ammonoxidation. | 2010-04-29 |
20100105941 | NOVEL COMPOUND FOR COLOR-PRODUCING COMPOSITION, AND RECORDING MATERIAL - A urea-urethane compound having one or more urea groups and one or more urethane groups in the molecular structure, the number of said urea groups (A) and the number of said urethane groups (B) satisfying the following numerical formula: | 2010-04-29 |
20100105942 | Process for the Synthesis of Aryloxypropylamine and Heteroaryloxypropylamine - The present invention relates to a process for the synthesis of aryloxypropylamine and heteroaryloxypropylamine of formula I: | 2010-04-29 |
20100105943 | HYPERBRANCHED POLYESTERS - The present invention relates to new hyperbranched polyesters based on oligohydroxycarboxylic acids with defined functionality. | 2010-04-29 |
20100105944 | Improvements in Oxidative Demetalling - Oxidative recovery methods that use oxygen or air for recovery of homogeneous metal catalysts, such as cobalt catalysts, used in for example hydroformylation processes, can be hazardous. Explosive or flammable gas mixtures may be generated inside the process equipment, which can deflagrate upon any ignition source such as a static electricity discharge. The use of a flammable diluent has been found to be a very effective way of optimizing the recovery method, by bringing the resulting gas mixtures above their upper flammability limit. The offgas produced is then also easier to dispose of as a fuel, as compared to when a non-flammable diluent is used. | 2010-04-29 |
20100105945 | NOBLE METAL CATALYSTS - Catalyst systems consisting of supported or unsupported transition metal catalysts which have modifiers on the surface. The modifiers have sulphur-containing functionalities (G | 2010-04-29 |
20100105946 | Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol) - Poly(ethylene glycol) carbamate derivatives useful as water-soluble pro-drugs are disclosed. These degradable poly(ethylene glycol) carbamate derivatives also have potential applications in controlled hydrolytic degradation of hydrogels. In such degradable hydrogels, drugs may be either trapped in the gel and released by diffusion as the gel degrades, or they may be covalently bound through hydrolyzable carbamate linkages. Hydrolysis of these carbamate linkages releases the amine drug at a controllable rate as the gel degrades. | 2010-04-29 |
20100105947 | PROCESS FOR THE PRODUCTION OF ALKYL ALKOXYACETATES - A process for the production of lower alkyl alkoxyacetates, preferably methyl methoxyacetate, by reaction of a di-(lower alkoxy)methane, preferably dimethoxymethane, with the acid form of a medium-pore or large-pore zeolite catalyst, preferably the acid form of faujasite, ZSM-5, mordenite, or beta, in the gas phase at atmospheric or near-atmospheric pressures. | 2010-04-29 |
20100105948 | HOP ALPHA ACID OR HOP OIL CONTENT ENHANCER - To provide a hop alpha acid or hop oil content enhancer, which increases the content of a hop alpha acid or a hop oil. | 2010-04-29 |
20100105949 | RADIOSYNTHESIS OF ACID CHLORIDES - Radiolabelled acid chlorides may be synthesised by reacting a radiolabelled carboxylic acid with a solid-phase supported chlorinating agent. | 2010-04-29 |
20100105950 | METHOD FOR PRODUCING KETAZINE COMPOUND - A process for preparing a ketazine compound of the formula (1) from a ketone compound of the formula (2), ammonia and an oxidizing agent, wherein a solution containing the ketone compound of the formula (2) and ammonia is brought into contact with an aqueous solution of the oxidizing agent in a tubular reactor having a flow channel width of 2 to 10000 μm | 2010-04-29 |
20100105951 | PROCESS FOR PREPARING DIPHENYLMETHANEDIAMINE - The invention provides a process for preparing diphenylmethanediamine, comprising the steps of
| 2010-04-29 |
20100105952 | PROCESS FOR THE SYNTHESIS OF DMAPA - The present invention relates to a process for the industrial preparation of a diamine starting from a corresponding alkenyl nitrile comprising at least one C—C double bond, which comprises the steps
| 2010-04-29 |
20100105953 | Human Adam-10 Inhibitors - The present invention provides compounds useful for inhibiting the ADAM-10 protein, with selectivity versus MMP-1. Such compounds are useful in the in vitro study of the role of ADAM-10 (and its inhibition) in biological processes. The present invention also comprises pharmaceutical compositions comprising one or more ADAM-10 inhibitors according to the invention in combination with a pharmaceutically acceptable carrier. Such compositions are useful for the treatment of cancer, arthritis, and diseases related to angiogenesis. Correspondingly, the invention also comprises methods of treating forms of cancer, arthritis, and diseases related to angiogenesis in which ADAM-10 plays a critical role. | 2010-04-29 |
20100105954 | PROCESS FOR PREPARING TETRAFLUOROBENZENE CARBALDEHYDE ALKYL ACETAL - A process for preparing tetrafluorobenzene carbaldehyde alkyl acetal represented by the following formula (II), comprising reducing tetrafluorocyanobenzene represented by the following formula (I) with a metal catalyst containing a platinum group metal in the presence of an alkyl alcohol represented by R—OH (R is an alkyl group of 1 to 4 carbon atoms) and an acid; (I) wherein m is 1 or 2, n is 0 or 1, and m+n is 2, (II) wherein m and n are the same as those in the formula (I), and R is an alkyl group of 1 to 4 carbon atoms. | 2010-04-29 |
20100105955 | METHODS AND COMPOSITIONS FOR PRODUCING FATTY ALDEHYDES - Methods and compositions, including nucleotide sequences, amino acid sequences, and host cells, for producing fatty aldehydes are described. | 2010-04-29 |
20100105956 | Internal Loop Reactor And OXO Process Using Same - The invention relates to improvements in internal loop reactors. The reactor of the invention is characterized by a plurality of cooling tubes which form the annulus between the riser and the downcomer path of said internal loop reactor. The reactor also provides improvements in hydroformylation reactions using the improved reactor. | 2010-04-29 |
20100105957 | PROCESS FOR PRODUCING ACROLEIN AND GLYCERIN-CONTAINING COMPOSITION - The present invention provides a process for producing acrolein, which exhibits a prolonged catalyst life, low energy consumption, and excellent efficiency, and which is earth-conscious, and a glycerin-containing composition which can preferably be used even in this process. The process for producing acrolein is one which includes bringing a raw material gas containing glycerin gas into contact with a solid acid catalyst in a reactor, and the partial pressure of the glycerin gas in the raw material gas is set to be from 0.01 to 30 kPa. The glycerin-containing composition is for use in a process for producing acrolein using a solid catalyst and includes a fatty acid and/or a fatty acid ester, and a total mass of the fatty acid and the fatty acid ester is from 0.001% to 5% by mass, relative to the glycerin. | 2010-04-29 |
20100105958 | Specific Polybranched Polyaldehydes, Polyalcohols, and Surfactants, and Consumer Products Based Thereon - Acyclic polyaldehydes and polyalcohols having 11, 16 or 21 carbon atoms and comprising at least two aldehyde or hydroxyl alcohol groups, at least three branches, and three or less carbon-carbon double bonds. | 2010-04-29 |
20100105959 | PROCESS FOR THE REMOVING POLY(PROPYLENE OXIDE) FROM PROPYLENE OXIDE BY MEMBRANE SEPARATION - The invention relates to a process for removing poly(propylene oxide) from propylene oxide by membrane separation, wherein a membrane having an average pore size of from 0 to 5 nm is used. In said process, a liquid feed comprising propylene oxide and poly(propylene oxide) may be separated by the membrane into a permeate comprising propylene oxide and either no poly(propylene oxide) or poly(propylene oxide) at a concentration which is lower than the poly(propylene oxide) concentration in the feed, and a retentate comprising propylene oxide and poly(propylene oxide) at a concentration which is higher than the poly(propylene oxide) concentration in the feed. | 2010-04-29 |
20100105960 | PROCESS FOR RECOVERING PHENOL FROM A BPA WASTE STREAM - An improved process for recovering phenol from a bisphenol-A residue stream by reconfiguring the distillation column and the cracking reactor in a way that separates the reboil/distillation heat load and the cracking heat load, so that separate heat sources are used. | 2010-04-29 |
20100105961 | CRYSTAL POLYMORPH OF FLUORENE DERIVATIVE AND PRODUCTION METHOD THEREOF - A method of producing a crystal polymorph of 9,9-bis(4-(2-hydroxyethoxy)phenyl)fluorene, comprising the steps of
| 2010-04-29 |
20100105962 | CATALYTIC HYDROGENATION OF CARBON DIOXIDE INTO SYNGAS MIXTURE - The invention relates to a process of making a syngas mixture containing hydrogen, carbon monoxide and carbon dioxide, comprising a step of contacting a gaseous feed mixture containing carbon dioxide and hydrogen with a catalyst, wherein the catalyst substantially consists of chromia/alumina. This process enables hydrogenation of carbon dioxide into carbon monoxide with high selectivity, and good catalyst stability over time and under variations in processing conditions. | 2010-04-29 |
20100105963 | METHODS AND COMPOSITIONS FOR PRODUCING FATTY ALCOHOLS - Methods and compositions, including nucleotide sequences, amino acid sequences, and host cells, for producing fatty alcohols are described. | 2010-04-29 |
20100105964 | Process for the manufacture of dichloropropanol - Process for manufacturing dichloropropanol according to which, a) in a liquid reaction medium containing water, which is in contact with a gaseous phase, glycerol is reacted with hydrogen chloride under a partial pressure of hydrogen chloride in the gaseous phase greater than 0.2 bar absolute, and b) at least part of the liquid reaction medium and optionally part of the gaseous phase from step a) is (are) subjected to at least one separation operation and, prior to said separation operation, the part of the liquid reaction medium and the part of the gaseous phase from step a) is (are) subjected to bi) at least one treatment for reducing the weight ratio between the hydrogen chloride and the water in the part of the liquid reaction medium so as to attain a ratio less than or equal to the weight ratio between the hydrogen chloride and the water in the binary azeotropic hydrogen chloride/water composition at total pressure of the separation operation, and/or bii) at least one treatment for reducing the weight ratio between the water and the dichloropropanol in the part of the liquid reaction medium so as to attain a ratio less than or equal to the weight ratio between the water and the dichloropropanol in the ternary water/dichloropropanol/hydrogen chloride azeotrope at total pressure of the separation operation. | 2010-04-29 |
20100105965 | PROCESS AND APPARATUS FOR AZEOTROPIC RECOVERY OF DICHLOROHYDRINS - A process and apparatus for recovering dichlorohydrins from a mixture comprising dichlorohydrins, water, one or more compounds selected from esters of dichlorohydrins, monochlorohydrins and/or esters thereof, and multihydroxylated-aliphatic hydrocarbon compounds and/or esters thereof, and optionally one or more substances comprising chlorinating agents, catalysts and/or esters of catalysts is disclosed. A liquid aqueous phase is recycled to the distillation column while distilling or fractionating the mixture to separate dichlorohydrin(s) and water from the mixture. Advantages include more efficient recovery of dichlorohydrins for a given distillation column, less waste due to avoiding the conditions conducive to the formation of heavy byproducts, and reduced capital investment in recovery equipment. | 2010-04-29 |
20100105966 | ETHYLENE GLYCOL REMOVAL OF RESIDUAL GLYCOL IMPURITIES - A process includes receiving a process stream including at least about 80.0% by weight propylene glycol, and contacting the process stream with an absorbent material to produce a product stream. The absorbent material is configured to preferentially absorb ethylene glycol relative to propylene glycol. | 2010-04-29 |
20100105967 | CONVERSION OF 2-CHLORO-1,1,1,2-TETRAFLUOROPROPANE TO 2,3,3,3-TETRAFLUOROPROPENE - Described is a method for producing fluoropropenes of formula CF | 2010-04-29 |
20100105968 | PRODUCTION PROCESS FOR CHLORINE-CONTAINING FLUORINE-CONTAINING COMPOUND - The production process of the present invention for a chlorine-containing fluorine-containing compound is characterized in that a reaction of adding chlorine atoms to a carbon-carbon unsaturated bond of a hydrogen-containing compound having a carbon-carbon unsaturated bond is carried out under the presence of a fluorine gas. The hydrogen-containing compound having a carbon-carbon unsaturated bond may be 3,4-dichlorobutene-1. Further, the present invention provides a process for producing efficiently and economically 1,2,3,4-tetrachlorohexafluorobutane from 3,4-dichlorobutene-1 described above. According to the present invention, chlorination and fluorination of the hydrogen-containing compound having a carbon-carbon unsaturated bond are carried out in a single step, and therefore a chlorine-containing fluorine-containing compound can be more economically produced at a higher yield than in a conventional process in which two reactions are individually carried out. | 2010-04-29 |
20100105969 | METHOD OF PRODUCING IODIZING AGENT, AND METHOD OF PRODUCING AROMATIC IODINE COMPOUND - A method of the present invention, for producing an iodizing agent, includes the step of electrolyzing iodine molecules in a solution by using an acid as a supporting electrolyte. This realizes (i) a method of producing an iodine cation suitable for use as an iodizing agent that does not require a sophisticated separation operation after iodizing reaction is completed, and (ii) an electrolyte used in the method. Further, a method of the present invention, for producing an aromatic iodine compound, includes the step of causing an iodizing agent, and an aromatic compound whose nucleus has one or more substituent groups and two or more hydrogen atoms, to react with each other under the presence of a certain ether compound. This realizes such a method of producing an aromatic iodine compound that position selectivity in iodizing reaction of an aromatic compound is improved. | 2010-04-29 |
20100105970 | BIOMASS CONVERSION PROCESS - A method for converting solid biomass into hydrocarbons includes contacting the solid biomass with a catalyst in a first riser operated at a temperature in the range of from about 50° C. to about 200° C. to thereby produce a first biomass-catalyst mixture and a first product comprising hydrocarbons; a) separating the first product from the first biomass-catalyst mixture; c) charging the first biomass-catalyst mixture to a second riser operated at a temperature in the range of from about 200° C. to about 400° C. to thereby produce a second biomass-catalyst mixture and a second product comprising hydrocarbons; d) separating the second product from the second biomass-catalyst mixture; e) charging the second biomass-catalyst mixture to a third riser operated at a temperature greater than about 450° C. to thereby produce a spent catalyst and a third product comprising hydrocarbons; and f) separating the third effluent from the spent catalyst. | 2010-04-29 |
20100105971 | SEPARATION METHOD OF AROMATIC COMPOUNDS COMPRISING SIMULATED MOVING BED XYLENE MIXTURE PRE - TREATMENT PROCESS AND ADDITIONAL XYLENE ISOMERIZATION PROCESS - Disclosed is a method for separating aromatic compounds using a simulated moving bed adsorptive chromatography and a crystallization process, comprising a sulfolan process that is a non-aromatic compound removing process, a benzene/toluene fractionation process, an aromatic compound fractionation process, a selective toluene disproportionation process, a transalkylation process, a crystallization process for para-xylene separation, a simulated moving bed para-xylene separation process and a xylene isomerization process, wherein the method is characterized by further comprising a simulated moving bed xylene mixture pre-treatment process and an additional xylene isomerization process. The separation method of aromatic compounds according to the present invention can make significant improvement in para-xylene and benzene production in the overall process, as compared to the conventional aromatic compound separation process. | 2010-04-29 |
20100105972 | Hydrocarbon Synthesis - A method of synthesizing hydrocarbons from smaller hydrocarbons includes the steps of hydrocarbon halogenation, simultaneous oligomerization and hydrogen halide neutralization, and product recovery, with a metal-oxygen cataloreactant used to facilitate carbon-carbon coupling. Treatment with air or oxygen liberates halogen and regenerates the cataloreactant. | 2010-04-29 |
20100105973 | ABSORBER DEMETHANIZER FOR METHANOL TO OLEFINS PROCESS - A process for conversion of methanol to olefins (MTO), including: contacting methanol and air in a methanol-to-olefins reactor; recovering an effluent from the methanol-to-olefins reactor comprising methanol, ethylene, and nitrogen oxides; separating the effluent via one or more reactive distillation and/or distillation stages using a hydrocarbon absorbent to recover a first fraction comprising ethylene and a second fraction comprising methane; wherein the separating comprises operating the one or more extractive distillation and/or distillation stages at temperatures and pressures sufficient to prevent any substantial conversion of nitrogen oxides to N | 2010-04-29 |
20100105974 | Mixture of Catalysts for Cracking Naphtha to Olefins - A process is presented for the selective catalytic cracking of naphtha to light olefins. The process includes contacting a naphtha feedstream with a mixture of catalysts to reduce the amount of recycle, and especially the recycle of light paraffins. The mixture of catalysts includes a first molecular sieve made up from a small pore zeolite having a pore index between 13 and 26, and a second molecular sieve made up from an intermediate pore zeolite having a pore index between 26 and 30. | 2010-04-29 |
20100105975 | Nuclear Assisted Hydrocarbon Production Method - A method is disclosed for the temporary or permanent storage of nuclear waste materials comprising the placing of waste materials into one or more repositories or boreholes constructed into an unconventional oil formation. The thermal flux of the waste materials fracture the formation, alters the chemical and/or physical properties of hydrocarbon material within the subterranean formation to allow removal of the altered material. A mixture of hydrocarbons, hydrogen, and/or other formation fluids are produced from the formation. The radioactivity of high-level radioactive waste affords proliferation resistance to plutonium placed in the periphery of the repository or the deepest portion of a borehole. | 2010-04-29 |
20100105976 | Method for treating mineral sludge above ground using polymers - Provided is a method for treating sludge from the mining or mineral industry, including before above-ground spreading, contacting the sludge with a flocculating agent that is a water-soluble, organic polymer having a molecular weight of from 5,000,000 to 25,000,000 g/mol and an anionicity of from 10 to 40 mol %, to produce contacted sludge, wherein the water-soluble organic polymer includes at least one anionic monomer having a carboxylic function or having a sulfonic acid function, at least one non-ionic monomer, and optionally one or more cationic monomers, where the flocculating agent is branched, and has from 0.02 to 2 mol % hydrophobic monomers. | 2010-04-29 |
20100105977 | METHOD FOR PROVIDING PHOTOTHERAPY TO THE BRAIN - A therapeutic treatment system and method are provided. The therapeutic system includes a light source adapted to irradiate at least a portion of the brain with light and a non-light energy source adapted to apply non-light energy to the at least a portion of the brain. The therapeutic treatment method includes irradiating at least a portion of a patient's brain with light and applying a non-light energy to the at least a portion of the patient's brain. The therapeutic treatment method provides therapeutic treatment without damaging the scalp tissue of the patient. | 2010-04-29 |
20100105978 | HEART ASSIST DEVICE - Heart side magnets | 2010-04-29 |
20100105979 | Surgical Needle and Anchor System with Retractable Features - Various surgical introducer needle and anchor systems are provided. The systems can include an introducer needle and a tissue support implant or sling device. The implant device can include one or more anchoring devices. The introducer needle device can include a handle assembly and a needle assembly. The needle assembly can include a generally hollow needle, and a wire traversable therein. The wire can include a distal tip adapted to selectively retract or withdraw from the engaged anchoring device upon deployment of the anchor and/or implant. | 2010-04-29 |
20100105980 | MOTOR AND ENDOSCOPE PROBE EQUIPPED WITH MOTOR - A motor which can be mounted in an endoscope probe without bending an electric power supply wire in an endoscope probe body, and an endoscope probe using the motor are provided. The motor includes a magnet, a field coil, a housing, an electric power supply wire, and a shaft. A lead wire from the field coil is connected to the electric power supply wire. A cutout is provided in a housing end, and the electric power supply wire is received along the cutout and led out to the outside of the motor in the direction in which a shaft projects. When the motor is mounted in the endoscope probe, the motor is placed in the endoscope probe body so that the shaft projects in the direction opposite to the direction of the front end of the endoscope probe, and the electric power supply wire, which is led out to the outside of the motor, is routed along the longitudinal direction of the endoscope probe. | 2010-04-29 |
20100105981 | Puncturing Instrument - The invention relates to a puncturing instrument comprising a guiding tube at the distal end of which an expanding anchor means is disposed and a protective sleeve enclosing at least the distal end portion of the guiding tube especially in the area of the expanding anchor means to be axially displaceable, wherein a hollow needle or a gastroscope having a distal end in the form of a cutting edge is supported to be axially movable inside or along the guiding tube. | 2010-04-29 |
20100105982 | Fluid Seal for Endoscope - A seal is provided for effectively inhibiting the egress of fluids from the working channel of an endoscope when an elongate device having a region with a non-circular cross-sectional shape is disposed therein. The seal has a body portion with a proximal end adapted for insertion of the elongate device, a distal end adapted for connection to the proximal end of the endoscope, and a wall defining a lumen adapted to receive the elongate device and to provide access to the working channel of the endoscope. The seal includes a sealing element for sealing the region of the elongate device with a non-circular cross-sectional shape. The sealing element conforms to the profile of the non-circular region. | 2010-04-29 |
20100105983 | SYSTEM AND METHOD FOR NAVIGATING A TOOL WITHIN A BODY CONDUIT - Apparatus and method for navigating surgical tools within a body cavity. Embodiments of the invention are particularly useful for displacing a surgical tool within a body conduit such as an intestine. Embodiments comprise a balloon catheter having a shaft, and a surgical tool operable to slide along that shaft. In some embodiments the surgical tool comprises a second balloon catheter. | 2010-04-29 |
20100105984 | System and Method for Guiding a Medical Instrument with Magnetic Force Control - A magnetic force control system for guiding a medical instrument within a body includes: a controlled magnet coupled to the medical instrument; a controller magnet that exerts a magnetic force on the controlled magnet; a magnetically permeable shield, placed between the controlled magnet and the controller magnet, that selectively modulates the magnetic force by rerouting magnetic field lines; and a control system. A method for guiding a medical instrument within a body with magnetic force control includes: providing a controlled magnet coupled to the medical instrument, inserting the controlled magnet and medical instrument into the body, providing a controller magnet outside the body, placing a magnetically permeable shield between the controlled magnet and the controller magnet, applying magnetic force, and selectively modulating the magnetic force with the shield to vary at least one of amplitude and orientation of the magnetic force, thereby guiding the controlled magnet within the body. | 2010-04-29 |
20100105985 | Surgical retractor extensions - A surgical retractor apparatus having one or more independent, removable extension members adapted to be mounted at the distal end of the retractor, or between the blades of a spreadable retractor, after the retractor has been positioned in the patient, such that a significant portion of the extension member extends beyond the distal end of the retractor to preclude or minimize intrusion of tissue into the access area created by the retractor. The extension members may vary in size and shape so that the most appropriate extension member can be chosen to address the intrusion problem, and the extension members may be mounted at various fixed locations, using clips, mechanical interlocking structures or the like. | 2010-04-29 |
20100105986 | Surgical Access System and Related Methods - A system for accessing a surgical target site and related methods, involving an initial distraction system for creating an initial distraction corridor, and an assembly capable of distracting from the initial distraction corridor to a secondary distraction corridor and thereafter sequentially receiving a plurality of retractor blades for retracting from the secondary distraction corridor to thereby create an operative corridor to the surgical target site, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site. | 2010-04-29 |
20100105987 | SURGICAL ACCESS SYSTEM AND RELATED METHOD - A surgical access system including a tissue distraction assembly and a tissue refraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site. | 2010-04-29 |
20100105988 | Portable Diagnostic Instrument and a Method for its Use - A portable diagnostic instrument for use by medical professionals. The portable diagnostic instrument can comprise a circuit control that can maintain the output of the light intensity constant, even when battery power is reduced. The circuit control system can also comprise a warning system to provide information about remaining battery life to the user. | 2010-04-29 |
20100105989 | MEDICAL GUIDE SYSTEM - [PROBLEMS] To provide a medial guide to doctors, patients, general users, and medical institutes. | 2010-04-29 |
20100105990 | METHOD OF MONITORING HYPERTENSIVE HAEMODIALYSIS PATIENTS - The invention relates to a calculation and control system for determining whether a patient intended to follow several sessions of hemodialysis treatment falls or not within one group among several groups of hypertension-affected patients, the system comprising:
| 2010-04-29 |
20100105991 | SYSTEM FOR REHABILITATION AND/OR PHYSICAL THERAPY FOR THE TREATMENT OF NEUROMOTOR DISORDERS - The invention discloses a sensor docking unit ( | 2010-04-29 |
20100105992 | Pressure-sensitive conductive yarn and biological information-measuring garment | 2010-04-29 |
20100105993 | METHODS AND APPARATUS FOR NONINVASIVE ISCHEMIC CONDITIONING - A method for ischemic conditioning treatment in a patient is provided. Transient ischemia is caused by interrupting blood flow to a tissue and a response to the ischemic conditioning treatments is monitored and the ischemia and response thereto is adjusted and controlled based on the monitoring results. | 2010-04-29 |
20100105994 | BIOLOGICAL INFORMATION MEASURING APPARATUS - There is provided a biological information measuring apparatus, which permits to release constriction of capillary vessels a human body to provide stable measurement results of biological information and a proper S/N ratio. The biological information measuring apparatus | 2010-04-29 |
20100105995 | BONE DENSITY METER - A bone density meter including a light emission unit which emits light toward a surface of a user's body. A light reception unit receives the light emitted from the light emission unit toward the body surface and propagated in a portion of the body that includes bone. A bone density computation unit determines the bone density based on the amount of light received by the light reception unit. The light emission unit emits light toward the body surface at a portion having a thin subcutis, and the light reception unit receives the light propagated in the body through the portion at which the subcutis is thin. | 2010-04-29 |
20100105996 | FINGER DEPLOYED DEVICE FOR MEASURING BLOOD AND PHYSIOLOGICAL CHARACTERISTICS - The present invention relates to a device for measuring blood and physiological characteristics by passing light through human tissue that is configured for deployment on a human finger. The device includes a lower finger-trough configured in the main housing of the device; a hingedly attached closeable lid that has an upper finger-trough configured for deployment of at least one finger stabilizing element, the lid being latchable in a closed position; a finger stabilizing element made of a material having flexibly soft malleable characteristics so as to sealingly engage the top of the finger; a light source that is deployed in the sloped end wall of the lower finger-trough adjacent to the lower portion of the finger tip; and an end cap the is deployable on the open end of the device when the lid is in the closed position, which enables calibration of the device with a minimum of light wave “noise” from ambient light. | 2010-04-29 |
20100105997 | CLOSED LOOP PARAMETER ADJUSTMENT FOR SENSOR MODULES OF AN IMPLANTABLE MEDICAL DEVICE - In general, the invention is directed toward an implantable medical device that includes a controller and a plurality of sensor modules. The controller may control the sensor modules to perform one or more sensor actions in order to facilitate a measurement. The sensor modules may store one or more operational parameters that control various aspects of the sensor actions performed by the sensor modules. The controller may automatically adjust one or more of the operational parameters based on results received from previous measurements in order to provide closed loop parameter adjustment of the operational parameters associated with the sensor modules. The controller may communicate with the sensor modules via a common bus. Example measurements include tissue perfusion measurements, blood oxygen sensing measurements, sonomicrometry measurements, and pressure measurements. | 2010-04-29 |
20100105998 | METHOD AND APPARATUS FOR SPECTROPHOTOMETRIC BASED OXIMETRY OF SPINAL TISSUE - A near infrared spectrophotometric sensor for non-invasive monitoring of blood oxygenation levels in a subject's spinal cord tissue and spinal cord blood vessels is provided. The sensor includes at least one light source and at least one light detector. The light source is operative to emit near infrared light signals of a plurality of different wavelengths. The light detector is operative to sense light signals emitted from the light source and passed through the subject's spinal tissue, and to produce a sensor signal representative of the sensed light signals The light source is separated from the light detector by a distance representative of a distance from a first vertebrae structure of a human spine to a second vertebrae structure of the human spine, to permit alignment of the light source and detector with the first and second vertebrae structure. | 2010-04-29 |
20100105999 | Graphical User Interface for Glucose Monitoring System - Graphical user interfaces (GUIs) for a medical device such as a blood glucose meter, systems and methods are provided. Embodiments include GUIs in which a user may navigate between icons and select certain display outputs which summarize all or certain glucose data over particular time periods. In certain embodiments, animated icons and/or graphs and/or text summaries may be provided. | 2010-04-29 |
20100106000 | Methods and Systems for Evaluating Glycemic Control - A method of evaluating glycemic control of a patient includes providing a pentagon having five axes radiating from a center of the pentagon. A first pentagon area formed by a first point, a second point, a third point, a fourth point, and a fifth point plotted on the five axes, respectively, is determined. A second pentagon area formed by a sixth point, a seventh point, an eighth point, a ninth point, and a tenth point plotted on the five axes, respectively, is determined. A glycemic control parameter is determined based on the first pentagon area and the second pentagon area. | 2010-04-29 |
20100106001 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2010-04-29 |
20100106002 | IMAGE DISPLAY APPARATUS, IMAGE DISPLAY METHOD, AND MAGNETIC RESONANCE IMAGING APPARATUS - According to an Magnetic Resonance Imaging (MRI) apparatus, a Region Of Interest (ROI) setting unit included in a control unit sets an ROI on each of a T | 2010-04-29 |